The pleiotropic effects of ghrelin and growth hormone secretagogues (GHS) on neurons and muscle cells suggest that these compounds could be developed for the treatment of amyotrophic lateral sclerosis (ALS). Here, GH1 is linked to amyotrophic lateral sclerosis.